AIP
MRK icon

ARS Investment Partners’s Merck MRK Stock Holding History

ARS Investment Partners’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.78M Sell
21,672
-394
-2% -$46.1K 0.12% 70
2026
Q1 		$2.65M Sell
22,066
-520
-2% -$60K 0.14% 66
2025
Q4 		$2.38M Sell
22,586
-2,933
-11% -$275K 0.14% 70
2025
Q3 		$2.14M Sell
25,519
-3,047
-11% -$251K 0.14% 72
2025
Q2 		$2.26M Sell
28,566
-92,982
-76% -$7.39M 0.16% 66
2025
Q1 		$12.1M Sell
121,548
-1,385
-1% -$129K 1.09% 30
2024
Q4 		$12.2M Buy
122,933
+1,141
+0.9% +$118K 1.1% 30
2024
Q3 		$13.8M Sell
121,792
-638
-0.5% -$75.8K 1.24% 29
2024
Q2 		$15.2M Sell
122,430
-262
-0.2% -$33.7K 1.45% 25
2024
Q1 		$16.2M Sell
122,692
-165
-0.1% -$20.3K 1.61% 21
2023
Q4 		$13.4M Buy
122,857
+4,731
+4% +$491K 1.48% 23
2023
Q3 		$12.2M Sell
118,126
-434
-0.4% -$46.8K 1.51% 23
2023
Q2 		$13.7M Sell
118,560
-1,280
-1% -$145K 1.6% 21
2023
Q1 		$12.7M Buy
119,840
+633
+0.5% +$68.3K 1.53% 22
2022
Q4 		$13.2M Sell
119,207
-13,989
-11% -$1.43M 1.76% 21
2022
Q3 		$11.5M Buy
133,196
+13,837
+12% +$1.24M 1.58% 22
2022
Q2 		$10.9M Sell
119,359
-599
-0.5% -$53.1K 1.49% 24
2022
Q1 		$9.84M Buy
119,958
+76
+0.1% +$5.99K 0.95% 33
2021
Q4 		$9.19M Buy
119,882
+3,102
+3% +$247K 0.84% 34
2021
Q3 		$8.77M Sell
116,780
-773
-0.7% -$58.8K 0.88% 34
2021
Q2 		$9.14M Sell
117,553
-6,398
-5% -$476K 0.93% 34
2021
Q1 		$9.12M Sell
123,951
-1,690
-1% -$125K 1.06% 32
2020
Q4 		$9.81M Sell
125,641
-637
-0.5% -$48.7K 1.21% 29
2020
Q3 		$9.99M Sell
126,278
-322
-0.3% -$25.2K 1.57% 21
2020
Q2 		$9.34M Buy
126,600
+15,921
+14% +$1.2M 1.76% 18
2020
Q1 		$8.13M Sell
110,679
-683
-0.6% -$53.7K 1.96% 18
2019
Q4 		$9.66M Sell
111,362
-659
-0.6% -$54.1K 1.62% 22
2019
Q3 		$9M Sell
112,021
-15,397
-12% -$1.23M 1.62% 24
2019
Q2 		$10.2M Buy
127,418
+13,813
+12% +$1.06M 1.71% 22
2019
Q1 		$9.02M Sell
113,605
-2,315
-2% -$173K 1.63% 24
2018
Q4 		$8.45M Sell
115,920
-413
-0.4% -$29.2K 1.79% 21
2018
Q3 		$7.88M Buy
116,333
+86,392
+289% +$5.5M 1.22% 27
2018
Q2 		$1.73M Buy
+29,941
New +$1.69M 0.28% 61
2016
Q2 		– Sell
-5,828
Closed -$294K – 91
2016
Q1 		$294K Buy
5,828
+443
+8% +$21.7K 0.07% 82
2015
Q4 		$271K Sell
5,385
-657
-11% -$33.1K 0.06% 82
2015
Q3 		$285K Sell
6,042
-231,321
-97% -$12.3M 0.07% 81
2015
Q2 		$12.9M Sell
237,363
-7,898
-3% -$443K 2.36% 14
2015
Q1 		$13.5M Sell
245,261
-15,968
-6% -$904K 2.5% 14
2014
Q4 		$14.2M Sell
261,229
-6,727
-3% -$375K 2.41% 12
2014
Q3 		$15.2M Buy
267,956
+129,886
+94% +$7.29M 2.31% 17
2014
Q2 		$7.62M Sell
138,070
-2,622
-2% -$143K 1.18% 30
2014
Q1 		$7.62M Sell
140,692
-1,019
-0.7% -$52.8K 1.34% 27
2013
Q4 		$6.77M Sell
141,711
-13,479
-9% -$616K 1.14% 30
2013
Q3 		$7.05M Sell
155,190
-4,601
-3% -$210K 1.2% 30
2013
Q2 		$7.08M Buy
+159,791
New +$7.14M 1.24% 29

Other funds holding MRK

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

ARS Investment Partners's MRK Position: Q2 2026 in Review

ARS Investment Partners reduced its Merck (MRK) stake by 1.8% in Q2 2026, selling an estimated $46.1K and leaving 21,672 shares worth $2.78M. The position accounts for 0.12% of the portfolio, ranked #70.

ARS Investment Partners first reported a position in MRK in Q2 2013 and has held it in 45 quarters since. The position peaked at $16.2M in Q1 2024. 1,153 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • ARS Investment Partners held 21,672 shares of Merck worth $2.78M as of Q2 2026.
  • ARS Investment Partners sold 394 Merck shares in Q2 2026, an estimated $46.1K.
  • Merck made up 0.12% of ARS Investment Partners's portfolio in Q2 2026, its #70 holding.
  • ARS Investment Partners first reported a position in Merck in Q2 2013 and has held it in 45 quarters since.
  • ARS Investment Partners's Merck position peaked at $16.2M in Q1 2024.
  • 1,153 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on ARS Investment Partners's 13F filing for Q2 2026, filed 9 Jul 2026.